Home Biotech Investors bail out after Gilead's drug pricing fight
 

Keywords :   


Biotech Investors bail out after Gilead's drug pricing fight

2014-12-24 00:59:28| Biotech - Topix.net

The biotechnology sector is having its worst day since April as investors fear health insurers and companies that manage patient's drug benefits will put new pressure on how much the industry can charge for breakthrough treatments. The selloff, prompted by Express Scripts Holding's announcement Monday that it would block its U.S. patients from getting Gilead Sciences's $1,100-a-pill hepatitis C medicine, sent the Nasdaq Biotechnology Index down 4.6 percent, the biggest one-day drop since April.

Tags: drug fight pricing investors

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11Hurricane Rafael Update Statement
07.11Summary for Hurricane Rafael (AT3/AL182024)
07.11Australia plans social media ban for under-16s
07.11Hurricane Rafael Update Statement
07.11Summary for Hurricane Rafael (AT3/AL182024)
07.11Moldova cleans up its act to attract foreign businesses
07.11Bank of England expected to cut interest rates
07.11Will Trump's victory spark a global trade war?
More »